GlassScriptPhysician profile
Scott Jeffrey Primack
NPI 1386609428
$1,311.39
in general payments reported to CMS, 2019-2025
28 companies · $87.32 in 2025
The $87.32 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $163 · 2021: $54.82 · 2022: $27.34 · 2023: $256 · 2024: $258 · 2025: $87.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $206.96 | 2019 | |
| Boston Scientific Corporation | $196.62 | 2023 | |
| Spr Therapeutics, INC | $177.23 | 2021-2024 | Sprint Pns System |
| International Rehabilitative Sciences, INC | $96.66 | 2024 | Rs 4i Plus Sequential Stimulator |
| Avanos Medical | $87.25 | 2020 | |
| Nevro Corp. | $51.04 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $46.90 | 2019 | |
| Pfizer INC. | $38.29 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $34.22 | 2025 | |
| Abbvie INC. | $32.75 | 2025 | |
| Novartis Pharmaceuticals Corporation | $28.45 | 2019 | |
| Globus Medical, INC. | $28.31 | 2024 | Harvest |
| Biogen, INC. | $26.19 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $23.45 | 2024 | Dca Systems Hemoglobin A1c Reagent Kit |
| Vanda Pharmaceuticals INC. | $23.12 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $22.97 | 2023 | Xeomin |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.00 | 2020 | |
| Ossur Americas, INC. | $20.35 | 2025 | |
| Abbott Laboratories | $18.87 | 2020 | |
| Amgen INC. | $17.18 | 2019 | |
| Shionogi INC | $16.23 | 2019 | |
| Fidia Pharma USA INC. | $15.94 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.44 | 2019 | |
| Lilly USA, LLC | $15.23 | 2019 | |
| Daiichi Sankyo INC. | $13.67 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.06 | 2020 | |
| Allergan, INC. | $12.75 | 2019 | |
| Stimwave Technologies Incorporated | $11.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Primack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.